Clinical Trials Logo

Clinical Trial Summary

Background: - Metabolism is what the body does to turn food into energy. Omega-3 fatty acids are substances found in foods such as cold-water fish and shellfish that are essential for good health. Researchers want to see the effect of two fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on metabolism. They may be beneficial to cardiovascular health. Objective: - To understand the effects of EPA and DHA on metabolism. Eligibility: - Healthy people ages 18 years or above with plasma triglyceride (a type of fat in the blood) levels of 100 mg/dL or higher Design: - The study will last 20 to 24 weeks. - Participants will have 4 visits to the NIH Clinical Center. These will include: - Medical history - Physical Fasting blood and urine tests - CAVI tests: blood pressure is taken in the arms and legs, and the heart is monitored. - Participants will take an EPA/DHA dietary supplement. They will take 4 gel capsules, 3 times a day, for 6 or 7 weeks. Then they will not take the capsules for 8 to 10 weeks (a wash-out period). They will then take the capsules again for 6 or 7 weeks. - Participants will keep a food journal.


Clinical Trial Description

This is a novel randomized crossover, double-blinded pilot study that aims to investigate the effects of different omega-3 fatty acids, namely EPA and DHA, on lipoprotein metabolism. Subjects will be unblinded for performance of measurements after they complete the study. Subjects will receive EPA or DHA supplements for approximately 6 weeks with a wash out period of 8 weeks between the two arms of the study. The study consists of 4 outpatient visits when laboratory or research samples and CAVI tests will be performed. A 7-day food diary, pill count, and red cell membrane n-3 levels will be monitored to assess compliance. Serum cholesterol is transported by lipoproteins, such as VLDL, LDL and HDL, which vary in their relationship to cardiovascular risk. LDL is proatherogenic, whereas HDL is cardio-protective. Fish oil supplementation, such as EPA and DHA, has been shown to reduce triglycerides. EPA supplementation has also been shown to lower LDL-C, whereas DHA can raise both LDL-C and HDL-C. These differential effects on lipoproteins may alter the cardiovascular protection afforded by fish oil supplementation. This study will test the hypothesis that EPA and DHA may differ in their LDL-C lowering ability because of differences in how they modulate plasma PCSK9 levels, which is a major determinant of LDL-C levels. In addition, we will assess other parameters related to lipoprotein composition and function that may impact the cardioprotective effect of EPA and DHA. Other reported beneficial effects of omega-3 fatty acid supplementation, such as decreased platelet coagulability, markers of inflammation and changes in guy microbiota, will also be monitored. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02514070
Study type Interventional
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase Phase 2
Start date October 30, 2015
Completion date July 23, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06208501 - The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.
Recruiting NCT03932058 - Proteomics Research of Osteosarcoma
Recruiting NCT04851145 - Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. N/A
Recruiting NCT04257877 - Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)
Recruiting NCT06097065 - Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
Completed NCT01151917 - Proteomics in Morbid Obesity After Bariatric Surgery N/A
Completed NCT03043365 - Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults Phase 2
Active, not recruiting NCT00397436 - Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation Phase 0
Active, not recruiting NCT04514744 - Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Loading and Unloading N/A
Not yet recruiting NCT06365320 - Association Between Training Load and Lactate and Other Metabolites Analyzed by Metabolomic and Proteomic Techniques N/A
Not yet recruiting NCT06247774 - Reducing Heart Failure Risk in Late-Life With Physical Activity N/A
Completed NCT03096535 - Cold Induced Activation of Brown Adipose Tissue in Humans N/A
Completed NCT03095846 - Cold Induced Activation of Brown Adipose Tissue in Winter Swimmers N/A
Recruiting NCT05307367 - Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms N/A
Not yet recruiting NCT05289895 - Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques